ANNX20261016P10
ANNX Oct 16 2026 10.00 Put (ANNX261016P00010000)
option OPRA

our mission is to develop disease-modifying therapeutics for patients suffering from neurological disorders such as huntington's disease and alzheimer's disease by targeting complement-mediated neurodegeneration (cmnd).